Company Overview and News

 
Hepatitis A outbreak linked to frozen pomegranates

2018-04-07 theage.com.au
A frozen food company previously linked to two outbreaks of hepatitis A in NSW has been linked to a third outbreak, after seven people in Sydney, the Central Coast and Wollongong became ill after eating frozen pomegranates.

 
Hepatitis A outbreak linked to frozen pomegranates

2018-04-07 smh.com.au
A frozen food company previously linked to two outbreaks of hepatitis A in NSW has been linked to a third outbreak, after seven people in Sydney, the Central Coast and Wollongong became ill after eating frozen pomegranates.

 
Ready-made deal gives Australian Wholefoods larger portion

2017-06-19 perthnow.com.au
AUSTRALIAN Wholefoods is planning to expand its footprint and employ up to 60 new staff at its Salisbury plant as its new joint venture with national food manufacturer Patties Foods takes hold.

 
Same Chinese farm suspected of producing frozen berries at centre of 2015 and 2017 recalls

2017-06-07 theage.com.au
The frozen berries recalled this month are understood to have been from the same shipment of fruit from China that caused the 2015 hepatitis A outbreak.

 
Same Chinese farm suspected of producing frozen berries at centre of 2015 and 2017 recalls

2017-06-07 smh.com.au
The frozen berries recalled this month are understood to have been from the same shipment of fruit from China that caused the 2015 hepatitis A outbreak.

 
Humble pie is crustworthy

2016-08-19 perthnow.com.au
PATTIES Foods says it is in a stronger financial position before a likely takeover by private equity after focusing more heavily on pies.

 
Stocks in red for third day

2016-06-02 at.theaustralian.com.au
The Australian sharemarket has endured a third day in the red, after a sell-off in the banking sector drove heavy falls in Thursday trade.

 
Banks weigh on stocks at noon

2016-06-02 at.theaustralian.com.au
The Australian sharemarket remains on track for a third day of falls as investors shun the banking sector.

 
Patties Foods backs $232m takeover

2016-06-02 news.theage.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

 
Patties Foods backs $232m takeover

2016-06-02 news.smh.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

 
Caution weighs on stocks

2016-06-02 at.theaustralian.com.au
The Australian sharemarket is on track for a third day of falls, extending losses as investors show caution ahead of an OPEC meeting tonight and US jobs data tomorrow night.

 
Pie maker Patties agrees to private equity takeover bid

2016-06-01 smh.com.au
Patties Foods, which owns brands such as Four'n Twenty pies and Nanna's frozen deserts, has backed a $230 million takeover bid from a private equity firm. 

 
Patties Foods board agrees to PEP takeover

2016-06-01 news.theage.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

 
Patties Foods accepts $232m private equity takeover

2016-06-01 abc.net.au
Patties Foods, the maker of brands such as Nanna's and Four 'N Twenty pies, has agreed to a $232 million private equity takeover bid.

 
Patties Foods board agrees to PEP takeover

2016-06-01 news.smh.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

19h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...